Vol 49 No 01

The technique fails to demonstrate benefits for prostate cancer recurrence and metastases.

“Instead of just offering a select-few treatment options, ideally you would like to be able to offer patients a whole menu of treatments and have an educated conversation regarding the risks and benefits for each of these treatment options," says Rian Dickstein, MD.

"I’m just praying for it to go back to the way it was in 2019, honestly," says 1 urologist.

Among the changes are increases in phase-out ranges for traditional and Roth IRAs.

Because of the limitations of the research, the findings need to be considered with caution, said Lourdes Guerrios-Rivera, MD, MSc.

Improvements in technology have renewed interest in the technique.